Symbols / GRCE $4.31 -7.51% Grace Therapeutics, Inc.

Healthcare • Biotechnology • United States • NCM
GRCE Chart
O: — H: — L: — C: — V: —
SMA 20: SMA 50: SMA 200:
About

No company description available for this symbol.

Fundamentals
Scroll to Statements
Market Cap 66.69M Enterprise Value 48.02M Income -5.98M Sales Book/sh 4.19 Cash/sh 1.21
Dividend Yield Payout 0.00% Employees 6 IPO P/E Forward P/E -6.68
PEG P/S P/B 1.03 P/C EV/EBITDA -4.27 EV/Sales
Quick Ratio 14.56 Current Ratio 14.96 Debt/Eq LT Debt/Eq EPS (ttm) -0.31 EPS next Y -0.64
EPS Growth Revenue Growth Earnings 2026-02-12 ROA -10.84% ROE -10.22% ROIC
Gross Margin 0.00% Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 15.47M Shs Float 9.77M Short Float 12.57%
Short Ratio 3.31 Short Interest 52W High 5.18 52W Low 2.28 Beta 0.69 Avg Volume 509.95K
Volume 1.23M Target Price $11.49 Recom None Prev Close $4.66 Price $4.31 Change -7.51%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
Mean price target
2. Current target
Latest analyst target
3. DCF / Fair value
$-7.70
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
Low
High
Mean

No recent news from Yahoo. Try the RSS feed for latest GRCE news.

Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-02-11 Kavuru (Vimal) Director of Issuer 147,275 $3.40 $499,998
Financials

No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.

SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category